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Abstract
Background Medication errors are a significant global con-
cern and can cause serious medical consequences for
patients. Little is known about medication errors in Middle
Eastern countries. The objectives of this systematic review
were to review studies of the incidence and types of medi-
cation errors in Middle Eastern countries and to identify the
main contributory factors involved.
Methods A systematic review of the literature related to med-
ication errors in Middle Eastern countries was conducted in
October 2011 using the following databases: Embase, Med-
line, Pubmed, the British Nursing Index and the Cumulative
Index to Nursing & Allied Health Literature. The search strat-
egy included all ages and languages. Inclusion criteria were
that the studies assessed or discussed the incidence of medica-
tion errors and contributory factors to medication errors during
the medication treatment process in adults or in children.
Results Forty-five studies from 10 of the 15 Middle Eastern
countries met the inclusion criteria. Nine (20 %) studies fo-
cused on medication errors in paediatric patients. Twenty-one
focused on prescribing errors, 11 measured administration
errors, 12 were interventional studies and one assessed tran-
scribing errors. Dispensing and documentation errors were
inadequately evaluated. Error rates varied from 7.1 % to
90.5 % for prescribing and from 9.4 % to 80 % for adminis-
tration. The most common types of prescribing errors reported
were incorrect dose (with an incidence rate from 0.15 % to
34.8 % of prescriptions), wrong frequency and wrong
strength. Computerised physician rder entry and clinical phar-
macist input were the main interventions evaluated. Poor
knowledge of medicines was identified as a contributory
factor for errors by both doctors (prescribers) and nurses
(when administering drugs). Most studies did not assess the
clinical severity of the medication errors.
Conclusion Studies related to medication errors in theMiddle
Eastern countries were relatively few in number and of poor
quality. Educational programmes on drug therapy for doctors
and nurses are urgently needed.
Keywords Medication error . Middle East countries .
Prescribing . Administration . Transcribing
Introduction
The Middle Eastern region is strategically, politically and
economically important for the whole world. There are fifteen
countries between western Asia and northern Africa which
make up the Middle Eastern region [1]. Economically, Middle
Eastern countries are ranked by the World Bank according to
their gross domestic product (GDP) on purchasing power
parity (PPP) per capita. The high-income countries (HIC)
include Qatar, the United Arab Emirates (U.A.E), Bahrain,
Saudi Arabia, Kuwait, Israel and Oman. The upper-middle
income countries (UMIC) are Iran, Jordan and Lebanon. The
lower-middle iome countries (LMIC) are Egypt, Palestine,
Syria, Yemen and Iraq [1]. The population of the Middle
Eastern countries is approximately 300 million, with a popu-
lation growth rate of 1.86 %. Elderly people of 65 years or
over represent 3.63 % of the total population of Middle
Eastern people [2]. The International Diabetes Foundation
estimates that 26.6 million adults (8.6 % of the population)
in the Middle East and North Africa currently have diabetes
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[3]. Obesity rates in the Middle East and North Africa are also
among the highest in the world, particularly in the Gulf
countries.
Medication errors (MEs) are under-reported in all countries
[4], particularly in developing countries. MEs present a uni-
versal problem and can cause serious consequences for
patients, especially those with acute complex medical condi-
tions [5]. The National Patient Safety Agency revealed that
MEs in all care settings in the UK occurred in each stage of the
medication treatment process, with 16 % in prescribing, 18 %
in dispensing and 50 % in administration of drugs [6].
For paediatricMEs it has been estimated that 3–37% occur
during prescribing, 5–58 % during dispensing, 72–75 % dur-
ing administration, and 17–21% are documentation errors [7].
Over an 8-year period in the UK, at least 29 children died due
to MEs [8]. Safe drug therapy for children is a major issue in
many low-income countries (LIC) and LMIC in the south [9].
Most of the research on MEs has been conducted in HIC
in the USA and Europe. Information on the incidence of
MEs in LIC and LMIC is limited. In our current research,
we have focused on Middle Eastern countries in order to
explore and highlight the problem of MEs in this region.
There are a variety of reasons why MEs may be different in
this region. These include the training of health professio-
nals in clinical pharmacology, differences in relation to the
role of clinical pharmacists, and the types of medicines
prescribed, alongside cultural issues.
This systematic literature review therefore aimed to identify
and review studies of the incidence and types ofMEs inMiddle
Eastern countries, and identify the main contributing factors.
Methods
Search strategy
A systematic review of literature relating to MEs in prescrib-
ing, transcribing, dispensing, administration and documenta-
tion in adults and children in Middle Eastern countries was
conducted in October 2011. The following electronic data-
bases were searched: Embase (1980 –October 2011), Medline
(1948 – October 2011), Pubmed (until October 2011), the
British Nursing Index (1985 – October 2011) and the Cumu-
lative Index to Nursing & Allied Health Literature (CINAHL)
(1982 – October 2011). The search strategy included all ages,
all languages, and all types of trials and studies. References
from eligible articles were also hand-searched in order to
identify additional relevant papers.
Search terms
The following keywords were used as search terms: medication
error(s), prescribing error(s), dispensing error(s), administration
error(s), documentation error(s), transcribing error(s),
medication mistake(s), drug mistake(s), prescribing mis-
take(s), dispensing mistake(s), administration mistake(s),
transcribing mistake (s), wrong medication, wrong drug
(s), wrong dose(s), wrong route of administration,
wrong calculation(s), physician(s), pharmacist(s) and
nurse(s). Each of these key words were combined using
“OR” then combined using “AND” with Middle East
and also with the names of the appropriate countries (15
countries).
Review procedure
From previous systematic reviews of MEs, studies have
been found to be heterogeneous, as they were conducted
in different countries used different definitions and different
methods to collect data [10, 11]. For this reason we did not
try to analyse the data from a statistical viewpoint, but the
results are summarised according to the type of MEs.
Inclusion/exclusion criteria
We included all types of studies, i.e., randomised controlled
trials, non-randomised controlled trials, longitudinal studies,
cohort or case–control studies, and descriptive studies that
reported the incidence of medication errors or identified the
causes of MEs in the Middle East countries, either in adults
or children. We excluded reviews, letters, conference
papers, opinions, reports or editorial papers.
Quality assessment
A quality assessment of the identified studies was per-
formed. All relevant studies were reviewed according to
12 criteria adapted from two previous studies [11, 12]. The
criteria were adapted to apply to any type of MEs study.
Additionally, we evaluated or assessed the documented ethical
approval obtained for each study. We therefore evaluated the
papers according to the following 13 criteria:
1. Aims/objectives of the study clearly stated.
2. Definition of what constitutes a medication error.
3. Error categories specified.
4. Error categories defined.
5. Presence of a clearly defined denominator.
6. Data collection method described clearly.
7. Setting in which study conducted described.
8. Sampling and calculation of sample size described.
9. Reliability measures.
10. Measures in place to ensure that results are valid.
11. Limitations of study listed.
12. Mention of any assumptions made.
13. Ethical approval.
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Results
Search results
The results of this search strategy can be found in Fig. 1.
More than 5,000 articles were excluded, as the papers were
either not related to the specified countries or not relevant to
MEs. This left 204 articles for full-text review. A further 163
articles were excluded because they were not relevant to the
topic, not related to the specified countries or were opinion
articles, letters, editorials and reports.
Forty-one articles were identified as relevant. Four addi-
tional relevant studies were identified after hand-searching
of the references of these studies. Forty-five articles were
therefore finally relevant and are included in this systematic
review (Fig. 1). The abstracts of four studies were in English
but the full texts were in foreign languages (3 in Persian and
1 in Hebrew), and those papers were translated into the
English language.
Countries with data
The 45 studies provided data for 10 of the 15 countries
of the traditional Middle East (Fig. 2). These included
13 studies in Iran, 10 studies in Israel and 9 studies in
Saudi Arabia. There was no available data on MEs in
-
-
-
-
-
-
515 not relevant to the specified
countries
Databases: Embase, Medline, CINAHL,
British Nurse Index and Pubmed 
Identified studies
7,784
Removal of duplicates (n= 2498)
Titles & abstract screened
5,286
5,082 titles excluded due to:
4,448 not related to the topic 
119 Opinions, letters, editorials
and reports 
Full text studies reviewed
204
163 full texts excluded because
132 not relevant to the research
question
4 Studies were added 
from hand search
26  Commentaries, letters,
editorials and reports
Studies included in the review
45
countries
5 did not related to specified
Fig. 1 Flow chart for search
and review process
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the following countries: Yemen, Kuwait, Iraq, Oman and
Syria.
Quality assessment of studies
After the application of the quality assessment criteria which
were modified to apply to any type of MEs study, no study
met all the 13 criteria. Only one study fulfilled 10 criteria,
three studies met 9 criteria, and five met 8 criteria. The
remaining studies met less than 7 criteria (Fig. 3). Ten of
the 45 studies did not specify the type of MEs and 14 of the
45 studies did not clearly state whether or not ethical ap-
proval was obtained.
Types of medication error studies
Twenty-one of the 45 studies assessed prescribing errors
(Table 1). Most (seven) of these studies were conducted in
Saudi Arabia and in Israel (five). One study assessed tran-
scribing errors (Table 2). Eleven studies measured medica-
tion administration errors (Table 3) and most of these studies
were performed in Iran. Tables 4 and 5 contain the 12
intervention studies that have been performed in Middle
Eastern countries for adults and paediatric patients. Four of
these studies were conducted in Israel. No studies were
identified which evaluated dispensing errors and documen-
tation errors in Middle East countries. Nine (20 %) studies
out of the 45 studies focused on MEs in paediatric patients.
Incidence of medication errors
The incidence of MEs in this review is difficult to compare
between studies because different methodologies and differ-
ent definitions were used. We classified our results accord-
ing to where they occurred during the medication treatment
process, i.e., prescribing, transcribing and administration
(Fig. 4).
Prescribing errors
Prescribing errors have been defined as MEs initiated during
the prescribing process. These include the incorrect selec-
tion of medication, wrong dose, wrong strength, wrong
frequency, incorrect route of administration, inadequate in-
struction for use of a medication and wrong dosage form
[13]. Twenty-one (46 %) of the studies reported MEs that
occurred during the prescribing stage of the medication
process (Table 1). Eight studies identified in this review
used the above definition [14–21], while the remaining
studies did not clearly state a definition of prescribing errors.
Thirteen were prospective studies and were conducted in six
countries [14–20, 22–27]. Five were retrospective studies
[21, 28–31], and the remaining three studies were question-
naires [32–34]. Four studies assessed prescribing errors in
children [16, 17, 21, 29].
Estimates of the results were difficult to compare be-
tween studies because rates of error were expressed differ-
ently. Al-Khaja et al. reported the highest error rate, which
was 90.5 % of prescriptions in a primary health care centre
[16], while the lowest rate, reported by Al-Dhawailie, was
7.1 % of prescriptions in a teaching hospital [26]. The most
common types of prescribing errors reported among the
Middle Eastern countries were incorrect dose, wrong fre-
quency and wrong strength. This systematic review revealed
that the percentage of dosing errors that were reported
during medication prescribing ranged from 0.15 % to
34.8 % of the prescriptions (Table 6).
Transcribing errors
One prospective study of transcription errors using a direct
observational method was performed in Iran (Table 2) [35].
Transcribing errors were defined as any deviation in tran-
scribing a medication order from the previous step. This
study used a direct observation method of the transcribing
Fig. 2 Graph illustrating origin of included studies
Fig. 3 Quality assessment criteria of included studies
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Table 1 Studies describing prescribing errors
Country (Setting) Type of study Duration Sample Outcome Reference
Israel
(General hospital)
Prospective, prescriptions
were reviewed in pharmacy.
6 months 14,385
prescriptions
160 MEs were detected; 97 (60.6 %)
were prescribing errors; Incorrect
dosage (44) was the most common
type.
[14]
Bahrain
(Primary care)
Prospective, prescriptions
were collected
by pharmacists.
2 weeks 77,511
prescriptions
7.7 % of prescriptions contained
errors; Omission errors (93.6 %),
Commission errors (6.3 %).
[15]
Iran
(Teaching hospital)
Prospective, prescriptions
from elderly patients
were collected.
4 months 3000 prescriptions 829 (27 %) patients received at least
one inappropriate prescription;
746 (24 %) patients had at
least one medicine prescribed
in duplicate.
[22]
Bahrain
(Primary care)
Prospective, prescriptions
for infants were collected
by pharmacists.
2 weeks 2282 prescriptions 90.5 % of prescriptions contained
errors; 74.5 % of medications
contained drug errors; Dosing
frequency was incorrectly
written in 20.8 % and dose
strength was incorrectly
in 17.7 %.
[16]
Palestine (General
hospital)
Prospective, all patients
with creatinine clearance
≤59 ml/min were included,
data were collected from
patients’ files.
4 months 78 patients 63 (80 %) patients were having
at least one inappropriate
medication; 1.5—fold
greater than the recommended
dose, poor knowledge of
pharmacokinetics of
prescribed drug.
[23]
Egypt (Teaching
hospital, ICU)
Prospective, direct
observation by pharmacist
was conducted to record
medication-related problems.
1 year 220 patients 619 medication-related problems
were detected in 213 patients;
Incorrect dosing (22 %) was
the most common errors in ICU.
[24]
Bahrain
(Primary care)
Prospective, iron prescriptions
for infants were collected
and reviewed by pharmacist.
2 weeks 2,282 prescriptions 159 prescriptions included iron
preparation; 56 out of 159 were
issued without dosage forms
and duration of therapy.
[17]
Iran
(Teaching hospital)
Prospective, drug order
sheets in nephrology
ward were reviewed
by clinical pharmacist.
4 months 76 patients (818
medications)
86 (10.5 %) prescribing errors
were detected in 46 of the
admissions; wrong frequency
(37.2 %), wrong dose (19.8 %)
and overdose(12.8 %) were the
most common types of errors.
[18]
Saudi (Primary care) Prospective, prescriptions
were reviewed in public
and private centres
NR 600 prescriptions 64 (72 %) physicians were
classified as writing low-quality
prescriptions
[25]
Saudi
(Teaching hospital)
Prospective, medication
charts and orders data
collected by pharmacists
1 month 1582 medication
order
113 (7.1 %) prescribing errors
were detected; Wrong strength
39 (35 %) followed by wrong
dose frequency 26 (23 %).
[26]
Saudi
(Primary care)
Prospective, all medication
prescriptions were analysed.
1 working day 5299 prescriptions 990 (18.7 %) prescribing errors
identified; 8 (0.15 %) prescribing
errors had serious effect on the patients.
[27]
Bahrain
(Primary care)
Prospective, prescriptions
issued by the residents
were collected by
pharmacists
1 year 2692 prescriptions 2372 (88 %) prescriptions had errors;
total number of errors was 7139;
Incorrect dose and wrong dose
frequency (24.7 %) of errors.
[19]
Israel
(Teaching hospital)
Prospective, case–control
study
18 months 274 patients 137 MEs were identified; 63
(46 %) errors were prescribing.
[20]
Saudi
(Teaching hospital)
Retrospective, all
prescriptions
obtained from pharmacy
were analysed by physicians
and pharmacists.
1 year 3796 prescriptions 94 % of prescriptions had no
quantity indicated; 90.7 % of
prescriptions had incomplete
instructions for patients.
[28]
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process. The transcribing process involved prescriptions
being either transferred to the hospital pharmacy or dis-
pensed from ward-based stocks. When prescriptions were
sent to the pharmacy, all the information was transcribed
into the pharmacy information system. The pharmacy staff
then filled, checked and dispatched the drugs to the ward.
The observation process included review of each medication
order on the order sheet, its transcription, administration
nursing note and documentation of its prescriptions to the
pharmacy database. The study result revealed that over 50 %
of omission errors occurred at transcription stage.
Administration errors
Administration errors have been defined as a discrepancy
between the drug therapy received by the patient and that
Table 1 (continued)
Country (Setting) Type of study Duration Sample Outcome Reference
Iran
(Paediatric
hospital)
Retrospective, hospital
information-based study.
6 months 898 medical charts Incomplete information in 74 %
of medication orders; Time of
drug administration not reported
in 47.8 % of medical charts.
[29]
Israel (Teaching
hospital, ED)
Retrospective, charts review
was performed by two
physicians for adult patients
transferred by ambulance.
1 year 471 patient charts 24 (12.7 %) of 188 patients
receiving drugs in vehicle were
subject to MEs; In ED 120
(36 %) of 332 patients were
subject to MEs.
[30]
Saudi (Tertiary
hospital, PICU &
paediatric wards)
Retrospective of paediatric
physicians medication
orders.
5 weeks 2,380 medication
orders
1,333 MEs were reported; 1,051
(78.8 %) errors were potentially
harmful; Incidence rate was 56
per 100 medication order; Dose
errors were the highest incidence
(22 %).
[21]
Saudi
(General Hospital)
Medical records were
reviewed for adult patients.
2 years 2627 patient files 3963 MEs were identified; 60 % of
patient files contained one error;
30 % of patient files contained two
errors, and 3 errors or more found in
10 % of patient files. Wrong strength
was reported in 914 patients (35 %).
[31]
Israel
(Not applicable)
Questionnaire NR N/A 18 % of doctor orders were written
according to the hospital standard;
3 % of doctors and 25 % of nurses
were the rate of compliance in ED.
[32]
Israel
(Not applicable)
Structured questionnaire
sent to active physicians
to evaluate the rates and
types MEs that they
had encountered.
NR 627 physicians 470 (79 %) physician made an error
in prescribing; 376 (63 %)
physicians made more than one
error; 94 (16 %) physicians made
one error.
[33]
Saudi
(Primary care)
Self—administered
questionnaire designed
to explore factors
influencing prescribing.
NR 87 physicians 47 (54 %) physicians believed that
limited knowledge of pharmacology
is a main cause of prescribing errors;
65 % of physicians had not received
training in drug prescribing; 34 %
of physicians had consulted a
pharmacist before drug prescribing.
[34]
MEs: Medication Errors; NR: Not Reported, N/A: Not Available.
Table 2 Study describing transcribing errors
Country (setting) Type of study Duration Sample Outcome Reference
Iran (Teaching
hospital)
Prospective, direct observational
study to detect transcribing MEs.
5 months 287 medication charts 289 errors were identified with average
one error per chart; Omission error was
rated as the highest (52 %) transcription
error found in this study
[35]
MEs: Medication Errors
1000 Eur J Clin Pharmacol (2013) 69:995–1008
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intended by the prescriber or according to standard hospital
policies and procedures [36, 37]. Three studies used this
definition [38–40], while the remaining eight studies mainly
used general definitions of MEs rather than a medication
administration error definition. Two were prospective stud-
ies (Table 3) [38, 39]. One was an observational study in
Iran which assessed the administration of intravenous drugs
[38]. The other study, in Israel, used a variety of methods
(observations, interviews and administrative data) [39]. The
variation between the studies in definitions and methods
used for data collection made comparisons difficult. The
study that defined errors in preparation and administration,
found that the error rates were higher in the administration
process compared to the preparation process for intravenous
medications, and within the administration process the tech-
nique of administration of bolus injection was the most
common error (43.4 %) [38].
Two were retrospective studies [41, 42]. Seven were
questionnaire studies of nurses’ perceptions of administra-
tion errors [40, 43–48]. The reported administration error
rates ranged from 9.4 % to 80 % [38, 41]. Saab et al.
reviewed patient records and confirmed their results through
interviews with patients [41]. They found that the use of an
inappropriate drug was higher when patients used both over-
the-counter (OTC) and prescription medicines [41]. Sadat-
Ali and colleagues assessed the prevalence and character-
istics of MEs in patients admitted to a teaching hospital [42].
The authors found that the prevalence of MEs was low (1.58
per 1000 admission). This is likely due to the method used
in the study, which was a retrospective review of incident
reports—notorious for underestimation of error rates [42]. In
addition, the authors revealed that most of the MEs (50 %)
occurred during the night shift [42]. Seven questionnaire
studies were conducted (5 in Iran and 2 in Jordan). All these
studies evaluated nurses and student nurses opinion about
the drug administration errors in their area of work [40,
43–48] (Table 3).
Table 5 Interventional studies in paediatric and neonatal patients
Country(Setting) Intervention Duration Sample Outcome Reference
Israel (Children
Hospital, PCCD)
Pre/post implementation
of CPOE and CDSS
3 years 13124 drug orders in
first part 46970 orders
in second part
3 errors were identified in the first
part of the study (all were overdoses);
No errors were identified
in the second part.
[56]
Israel (Children
hospital, PICU)
CPOE implementation
in four different periods
3 years 5000 PICU
medication orders
273 (5.5 %) medication orders
contained prescription errors; 83 %
of prescription errors were reduced
after CDSS implemented.
[57]
Iran (Teaching hospital,
Neonatal ward)
Comparison between
physician order entry
(POE) and nurse order
entry (NOE) methods
effect on reducing
dosing MEs.
4 months 158 neonates 80 % of non-intercepted medication
errors in POE (period 1) occurred
in the prescribing stage compared
to 60 % during NOE (period 2);
Prescribing errors were decreased
from 10.3 % with POE to 4.6 %
with NOE period, respectively.
[58]
Iran (Teaching hospital,
Neonatal ward)
Comparison of CPOE effect
without and with CDSS
in three periods.
7.5 months 248 patients MEs rates before intervention
implemented (period 1) was 53 %;
Implementation of CPOE without
CDSS the MEs rate was 51 %; After
CDSS was added the MEs rate
was 34 %; Overdose was the most
frequent type of errors.
[59]
Egypt (Teaching
hospital, PICU)
Pre/post (physician
education; new medication
chart; physician feedback)
study of prescribing
errors in PICU.
10 months Pre :1417 medication
orders, Post: 1096
medication orders
1107 (78 %) orders had at least one
prescribing error; Significant
reduction in prescribing error rate
to 35 % post-intervention (P<0.001);
Severe errors reduced from 29.7 %
to 7 % after intervention.
[60]
PCCD: Paediatric Clinical Care Department; CPOE: Computerized Physician Order Entry; CDSS: Clinical Decision Support System; PICU:
Paediatric Intensive Care Unit.
Fig. 4 Study classification by stage of medication process
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Interventional studies
Twelve (27 %) studies were identified describing interven-
tions used to reduce MEs [49–60]. Of these, seven inter-
ventions were implemented in adult patients (Table 4)
[49–55], and five interventions in paediatric and neonatal
patients (Table 5) [56–60]. The interventions had been eval-
uated in studies from 3 months to 3 years, and most studies
involved a comparison of computerised drug order entry
systems, with or without clinical decision support systems
(CDSS), and/or with handwritten prescriptions. The out-
comes for all interventions were positive and led to the
prevention and reduction of MEs.
Four interventional studies examined the role of the clinical
pharmacist in reducingMEs [51–54]. All these studies were in
adult patients only. These interventions led to a significant
reduction in the number of MEs. Most of the errors detected
were in the prescribing stage. Incorrect drug dosing, incorrect
drug choice and drug interactions were the most common
errors detected by clinical pharmacists. One of the interven-
tion studies used a self-reported questionnaire designed to
collect data after the clinical pharmacists established training
and educational materials for inpatient nurses about MEs. No
ME data was actually observed or collected [51].
In paediatric and neonatal patients, computerised physi-
cian order entry interventions, with and without CDSS, was
the most commonly used intervention. All interventions that
were implemented in paediatric patients found that medica-
tion error rates decreased after the CDSS was added to the
computerised physician order entry system [56, 57, 59].
In addition, one study among the interventional studies in
paediatric patients was conducted to compare two medica-
tion order entry methods: the physician order entry (POE)
and nurse order entry [58]. The authors found that the error
rates decreased within the NOE period compared to the
errors within the POE period [58].
Types of errors
Incorrect dose was the most common type of error reported in
12 studies [14–21, 24, 26, 27, 30]. The dose error rates were
reported from0.15% to 34.8%of prescriptions errors (Table 6).
Other studies included wrong frequency errors [16, 17], wrong
strength [15, 16, 20, 25, 31], wrong or without dosage form [15,
16, 24, 27] and wrong duration of therapy [15, 16, 24, 27].
Medications involved
Differences in the reporting of medications between studies
were apparent; some studies involved the medication names,
and others listed only the therapeutic class. Most of the errors
were related to antihistamine drugs [16, 22, 27], antibiotic
medications [14, 23, 38, 60] and anticoagulant drugs [45, 54,
60]. In addition, medications reported in studies conducted on
paediatric patients found that antihistamines, paracetamol,
electrolytes and bronchodilator drugs were the most common
drugs associated with errors [16, 30].
Severity of reported medication errors
The majority of studies did not assess the clinical conse-
quences of reported MEs. Six (13 %, 6/45) attempted to
classify the severity of the MEs [14, 21, 26, 30, 31, 38]
(Table 7). Only one study reported the severity of the MEs
in detail, but was a retrospective study [21]. Two other
studies were retrospective [30, 31], while the other three
were prospective studies [14, 26, 38]. One study reported 26
deaths and felt that MEs were a contributory factor [31].
Factors contributing to medication errors
The determination of factors contributing to MEs is an
important aspect of this review because preventing MEs
Table 6 prescriptions with dosing errors
Country (setting) No. of Prescriptions or medication orders Dosing errors (number) Dosing errors (%) References
Israel (General hospital) 14,385 prescriptions 44 prescriptions 0.3 [14]
Bahrain (Primary care) 77,511 prescriptions 1,413 prescriptions 1.8 [15]
Bahrain (Primary care) 2,282 prescriptions 795 prescriptions 34.8 [16]
Egypt (Teaching hospital) 2,286 medication prescribed 503 medication prescribed 22 [24]
Bahrain (Primary care) 2,282 prescriptions 60 prescriptions 2.6 [17]
Iran (Teaching hospital) 86 prescriptions 11 prescriptions 12.8 [18]
Saudi (Primary care) 1,582 medication orders 14 medication orders 0.89 [26]
Saudi (Primary care) 5,299 prescriptions 8 prescriptions 0.15 [27]
Bahrain (Primary care) 5880 medication orders 397 medication orders 6.7 [19]
Israel (Teaching hospital) 4736 prescriptions 31 prescriptions 0.65 [20]
Israel (Teaching hospital) 471 medication orders 12 medication orders 2.5 [30]
Saudi (Tertiary hospital) 2,380 medication orders 526 medication orders 22.1 [21]
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from reaching the patient depends on a sound knowledge of
the causes or contributing factors. The factors contributing
to MEs were reported in 12 studies [15, 16, 19, 21, 26, 27,
31, 40, 42, 45–47]. The most common factors reported in
this review were as follows:
& Lack of knowledge of prescribing skills.
& Lack of pharmacological knowledge of physicians and
nurses.
& Poor compliance with drug prescribing and administra-
tion guidelines.
& Lack of reporting of MEs.
& Heavy workload and new staff.
& Miscommunications between health care professionals.
In general, poor knowledge of medicine prescribing and
administration was the most common reported contributory
factor of MEs in Middle Eastern countries [15, 16, 26, 31,
45, 47].
Discussion
The aim of this systematic review was to review studies of
the incidence and types of MEs in Middle Eastern countries
and to identify the main contributory factors involved. MEs
are an important variable in determining patient safety. This
review showed that there have been relatively few studies of
MEs in the Middle East compared to the number from the
US and Europe [61]. To our knowledge, no previous sys-
tematic review has evaluated MEs in Middle Eastern
countries. Additionally, the quality of the studies in the
Middle East was poor. Poor knowledge of clinical pharma-
cology was a major factor in many of the papers. This
systematic literature review has shown that the scientific
literature on MEs published in Middle Eastern countries is
limited. No information was available on five of the
countries included in the review. Many studies focused
mainly on adult patients.
Prescribing errors
Many differences were found with regard to how the stud-
ies obtained and reported data. Most of the studies in
Middle Eastern countries evaluated MEs during the pre-
scribing stage. The reported incidence of prescribing errors
in this review ranged from 7.1 % to 90.5 % of medication
orders. A high rate of prescribing errors is known to be an
international problem [61, 62]. In a previous systematic
review conducted in the UK to identify the prevalence,
incidence and nature of prescribing errors in hospital inpa-
tients, prescribing errors were found to be a common oc-
currence [61], and this is consistent with our findings. The
incidence of prescribing errors in that review were 2–14 %
of medication orders [61], which was lower than that found
in our review of MEs in Middle Eastern countries. How-
ever, another study in the UK found that prescribing error
rates vary widely, ranging from 0.3 % to 39.1 % of med-
ication orders [63]. It is possible that the incidence rate of
prescribing errors in the Middle Eastern countries is higher
than that reported in other countries in the world, for
example in the UK, but it could also be due to methodo-
logical differences.
Transcribing errors
Although some studies classified the transcribing stage as
the third most important area in the medication treatment
process, Lisby et al. identified the transcribing stage as the
area in which most errors occur [64]. In our review only one
study assessed transcribing errors, and found that over 50 %
of omission errors occurred at transcription stage; this is
consistent with other studies [64, 65]. The shortage of
Table 7 Clinical consequences and medicines of reported medication errors
Country Type of error Medicines Clinical consequences Reference
Israel Prescribing Anti-infectives, TPN, cytotoxics Errors divided into potentially serious, clinically significant
and clinically non-significant. MEs most frequent
in haemato-oncology and these were the errors
that were of greatest clinical significance
[14]
Saudi Arabia Prescribing Not stated Examples of potentially serious errors were given including
tenfold errors of amphotericin and captopril
[26]
Israel Prescribing Cardiovascular drugs 14 MEs (8 %) were clinically significant. There were
also 3 (2 %) severe MEs
[30]
Saudi Arabia Prescribing IV fluids, antibiotics, bronchodilators,
opioid analgesics, cardiovascular
drugs, sedatives
Majority of MEs were potentially harmful (1051, 79 %) [21]
Saudi Arabia Prescribing Antibiotics, cardiovascular drugs MEs were a contributory factor to 26 deaths [31]
Iran Administration Antibiotics, antacids, corticosteroids No clinically significant errors detected [38]
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studies in this stage of medication treatment may distort the
reality of the incidence rate of errors.
Administration errors
Our review showed that administration errors occurred in
9.4 % to 80 % of drug administrations. This is higher than
that reported in studies in HIC. Two observational studies
found that medication administration error rates in the acute
care setting varied between 14.9 % and 32.4 % in France
and Switzerland, respectively [66, 67].
In our review only one observational study determined
the frequency of MEs that occurred during the preparation
and administration of intravenous drugs in an intensive care
unit. It found that the rate of errors in drug administration
(66.4 %) was higher than in preparation (33.6 %) [38].
Another study found that the medication administration
error rate for intravenous medication is significantly higher
than other types of medication, the researchers observing the
preparation error rate as 26 % and the administration error
rate as 34 % [68]. Our findings therefore are also consistent
with the previous studies’ results highlighting that intrave-
nous MEs occur more frequently than preparation errors
[68]. In addition, Armitage and Knapman found that the
frequency of administration errors ranges from 2.4 % to
47.5 %, depending on the drug distribution system in place
[69]. The difference between the results of these studies may
be affected by the different definitions and different methods
used, and may also be due to the place of research and
settings. However, in the UK a recent report by National
Patient Safety Agency (NPSA) specified that 56 % of
reported errors associated with severe harm occurred at the
administration step [70].
Our results indicate that the most common types of errors
reported were incorrect drug dose, wrong frequency and
wrong strength during the prescribing stage. This is consis-
tent with previous studies’ results. In comparison, studies of
MEs in US and UK hospitals found that incorrect doses
were the most common type of error [71]. The UK National
Patient Safety Agency (2009) reported that the most com-
mon type of medication errors that occurred in the NHS was
a wrong dose or wrong frequency of medications [6], also
consistent with our findings.
Based on our review results, the main factor contributing
to MEs in Middle Eastern countries is poor knowledge of
medicines in both doctors (prescribers) and nurses (admin-
istering drugs), as was also the case with other studies’ [72].
Educational programmes for drug prescribers and nurses
concerning drug therapy are urgently needed to avoid drug
errors and to improve patient safety by clinical pharmacists
and clinical pharmacologists. Different studies have found
that clinical pharmacists play a significant role in delivering
training and competency assessment [73].
Limitation of this review
Some limitations of this review should be considered in
interpreting the results. The search strategy and search terms
were designed in order to be as comprehensive as possible,
but the databases used were directly biased to English-
language research and studies. We therefore may have
missed some studies because the original languages of the
included countries of the Middle East is not English; all of
the included countries speak Arabic except Iran (Persian)
and Israel (Hebrew).
Conclusion
As the first systematic review to describe MEs in Middle
Eastern countries, this review aimed to find out which scien-
tific literature has reported on or evaluated MEs in Middle
East countries. Although the studies related to MEs in the
Middle Eastern countries were relatively few in number, there
was a wide variation between studies in the error rates
reported, and this may due to the variations in their definitions
of medication errors, settings, the denominators and method-
ologies used. However, the quality of MEs studies that were
identified in this review was poor. Most of the studies were
conducted on adult patients, while very few MEs studies have
been performed in paediatric hospitals. Many studies focused
on prescribing errors and factors contributing to MEs. Our
findings highlighted that poor knowledge of medicines was a
contributory factor in both prescribers and nurses administer-
ing drugs.Middle Eastern countries urgently need to introduce
educational programmes to improve prescribing skills and
knowledge of prescribers, and to encourage nurses to improve
their quality of drug administration.
Suggested recommendations
According to the review results, the following recommenda-
tions are suggested to allow decision-makers to improve med-
ication safety and reduce MEs in Middle Eastern countries:
& Increase the awareness of MEs of health care professionals.
& Prescribers need to pay more attention to drug dosing.
& Improve medication error reporting systems and policy
among theMiddle Eastern countries by removing barriers,
clarifying the importance of reporting and encouraging
health care professionals to report medication errors.
& Clinical consequences of MEs should be assessed and
evaluated in future studies
& Carry out regular intensive educational and training
programmes in pharmacotherapy for undergraduate
medical and paramedical students.
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& Educational programmes by clinical pharmacists and
clinical pharmacologists on drug therapy are urgently
needed for doctors and nurses.
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